ACCELERATE DIAGNOSTICS INC's ticker is AXDX and the CUSIP is 00430H102. A total of 110 filers reported holding ACCELERATE DIAGNOSTICS INC in Q4 2019. The put-call ratio across all filers is 0.76 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $1,758,000 | -29.7% | 164,900 | 0.0% | 0.01% | -44.4% |
Q2 2020 | $2,500,000 | +82.0% | 164,900 | 0.0% | 0.01% | +28.6% |
Q1 2020 | $1,374,000 | -68.7% | 164,900 | -36.6% | 0.01% | -58.8% |
Q4 2019 | $4,394,000 | -9.0% | 260,000 | 0.0% | 0.02% | -15.0% |
Q3 2019 | $4,828,000 | -18.8% | 260,000 | 0.0% | 0.02% | -16.7% |
Q2 2019 | $5,949,000 | +8.9% | 260,000 | 0.0% | 0.02% | +4.3% |
Q1 2019 | $5,465,000 | +82.8% | 260,000 | 0.0% | 0.02% | +53.3% |
Q4 2018 | $2,990,000 | – | 260,000 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Birchview Capital, LP | 2,183,795 | $50,118,000 | 32.35% |
ORACLE INVESTMENT MANAGEMENT INC | 4,187,145 | $96,095,000 | 21.04% |
Selkirk Management LLC | 341,450 | $7,836,000 | 3.99% |
NEXT CENTURY GROWTH INVESTORS LLC | 607,067 | $13,932,000 | 1.62% |
Chicago Capital, LLC | 630,053 | $14,460,000 | 1.00% |
Cannell & Co. | 1,115,239 | $25,595,000 | 0.91% |
GRIFFIN ASSET MANAGEMENT, INC. | 252,893 | $5,804,000 | 0.85% |
Trellus Management Company, LLC | 24,648 | $566,000 | 0.82% |
OAKTOP CAPITAL MANAGEMENT II, L.P. | 155,000 | $3,557,000 | 0.79% |
ORACLE INVESTMENT MANAGEMENT INC | 967,900 | $2,993,000 | 0.66% |